Trial Profile
A phase I multiple-ascending dose clinical trial of APD371
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Oct 2020
Price :
$35
*
At a glance
- Drugs Olorinab (Primary)
- Indications Abdominal pain
- Focus Adverse reactions; Pharmacokinetics
- 23 Sep 2020 Results assessing safety and PK of single and multiple doses of olorinab in healthy adults from SAD and MAD studies presented at the 2020 American College of Clinical Pharmacology Annual Meeting
- 21 Mar 2020 Results assessing single and multiple dose PK and safety of olorinab in healthy adult subjects, presented at the 121st Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 07 Feb 2019 According to an Arena Pharmaceuticals media release, data from the study will be presented at Crohn's & Colitis Congress 2019.